Cystatin C, a Biomarker of AKI, as a Novel Predictor of Pre-term Labor in Severe Pre-eclampsia

Not Applicable

Completed

• Conditions: Preeclampsia with normal creatinine; Cystatin C, AKI, Preeclampsia, Pre- term Labor, Low Birth Weight

• Registration Number: TCTR20180730002
• Lead Sponsor: MSMC Grant contact number 461/2557

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-30
• Study Completion: 2018-08-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 26

Inclusion Criteria

Data was collected among pregnant women with a maternal age more than 18 years and is in the second half of pregnancy (gestational age >20
weeks). However, we included only severe preeclampsia with gestational age more than 28 week to our cohort.

Exclusion Criteria

Those with history or diagnosis of chronic hypertension, placenta previa, gestational diabetes, or chronic kidney disease with serum creatinine levels > 0.8 mg/dl were excluded

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
obstetric outcome at delivery Preterm labor, Low birthweight

Secondary Outcome Measures

Name	Time	Method
Renal outcome third trimester of pregnancy estimated GFR